Catalyst Wire Dossier Catalyst Wire Dossier

Lixiana

edoxaban · Daiichi Sankyo
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Lixiana, covering 2022-05-02 to 2026-04-20. Get the full timeline:

Most recent: EMA Authorised: Lixiana (edoxaban tosilate) — Daiichi Sankyo Europe GmbH

See pricing